RNA antagonist compounds for the inhibition of expression of mitochondrial glycerol-3-phosphate acyltransferase 1 (mtGPAT1)

Details for Australian Patent Application No. 2009265836 (hide)

Owner Santaris Pharma A/S

Inventors Lindholm, Marie; Straarup, Ellen Marie

Agent Wrays

Pub. Number AU-A-2009265836

PCT Pub. Number WO2010/000656

Priority 61/077,942 03.07.08 US; 08104623.7 03.07.08 EP

Filing date 24 June 2009

Wipo publication date 7 January 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2010/000656 Priority application(s): WO2010/000656

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009265841-Compounds useful for the prevention or treatment of accomodative asthenopia

2009265828-Power curtailment of wind turbines